Site: Canada ModificationFermer

Share Information

Share Price | Listing Information | Significant Shareholders | Dividend | Value transfer to Shareholders | Analyst Coverage | Analyst Consensus

Landis+Gyr has been listed on the SIX Swiss Exchange since July 2017.

Share Price

Listing Information

ListingSIX Swiss Exchange (International Reporting Standard)
Ticker symbolLAND
Swiss Security Number37115349
ISINCH0371153492
Nominal valueCHF 10.00
Issued shares29,251,249
IndicesSPI, SPI Extra, SPI ex SLI, Swiss All Share Index, UBS 100 Index, Ethos Swiss Governance Index, STOXX® All Europe 800
Accounting standardUS GAAP
AuditorPricewaterhouseCoopers

Significant Shareholders

ShareholderNumber of Shares% of voting rights
KIRKBI Invest A/S, Denmark4,445,26515.20%
Rudolf Maag, Switzerland3,000,00010.26%

All published notifications of holdings are available on the SIX Exchange Regulation website.

Dividend & Tax Value

Landis+Gyr’s dividend policy aims at a sustainable dividend payout of approximately 75% of free cash flow (excl. M&A). Statutory capital reserves available for distribution amounted to approx. CHF 883.7 million as of March 31, 2020.

YearTax valueDividendDetails
201777.60-ICTax
201855.152.301)ICTax
2019100.703.151)ICTax

1) Paid out of statutory capital reserves

Value Transfer to Shareholders

(CHF million)DividendShare buybackTotal
201867.9-67.9
201991.733.7125.4
Total159.633.7193.3

Analyst Coverage

The following analysts cover Landis+Gyr (last update in March 2020).

InstitutionAnalystContactRecommendation
CowenJeffrey Osbornejeffrey.osborne@cowen.com
+1 (646) 562 1391
Outperform
Credit SuissePatrick Laagerpatrick.laager@credit-suisse.com
+41 44 334 60 76
Outperform
J.P. MorganAndreas Williandreas.p.wili@jpmorgan.com
+44 20 7134 4569
Underweight
MirabaudDaniel KönigDaniel.Koenig@mirabaud-msl.com
+41 58 816 8872
Neutral
MizuhoMarvin Lomarvin.lo@hk.mizuho-sc.com
+852 2685 2031
Buy
Morgan StanleyBen Uglowben.uglow@morganstanley.com
+44 20 7425 8750
Underweight
Research PartnersUrs Emmingerurs.emminger@researchpartners.ch
+41 44 533 40 30
Buy
UBSFabian Haeckifabian.haecki@ubs.com
+41 44 239 1347
Neutral
VontobelMark Diethelmmark.diethelm@vontobel.com
+41 58 283 71 82
Hold

Analyst Consensus

Please find below the latest analyst consensus estimate that the investor relations team collects on a quarterly basis from sell-side analysts covering Landis+Gyr Group AG. Last updated May 2020.

Key Figures (USD in millions)Financial Year 2020/21 (n=8)Financial Year 2021/22 (n=8)Financial Year 2022/23 (n=7)
Net revenues1,5271,6811,752
Adjusted EBITDA174220233
Free Cash Flow94129143
Dividend per Share (CHF)2.583.313.66

Disclaimer:

The estimates and any related opinions, forecasts, projections, predictions or expectations, are the sole responsibility of the analysts concerned. Landis+Gyr Group AG has not commented on nor verified any (individual) estimates and it does not express any opinion on nor endorses the estimates or their correctness and accuracy in any way. Landis+Gyr Group AG accepts no liability in respect of the analyst consensus and undertakes no obligation to provide updates or revisions.

It should be noted that estimates are, by definition, forward looking and are therefore subject to risks and uncertainties which are subject to change at any time and which may materially affect eventual results.

This analyst consensus is provided for information purposes only. It should not be seen as a recommendation to buy or sell financial instruments in Landis+Gyr Group AG, or to take or refrain from taking any other action.